Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.
339 F.3d 1373 *; 2003 U.S. App. LEXIS 15496 **; 67 U.S.P.Q.2D (BNA) 1664 ***
SCHERING CORPORATION, Plaintiff-Appellant, v. GENEVA PHARMACEUTICALS, INC. and NOVARTIS CORPORATION, and TEVA PHARMACEUTICALS USA, INC., and ANDRX CORPORATION, ANDRX PHARMACEUTICALS LLC, and ANDRX PHARMACEUTICALS, INC., and MYLAN PHARMACEUTICALS, INC., and WYETH, ESI-LEDERLE, WYETH PHARMACEUTICALS, and WYETH CONSUMER HEALTHCARE (formerly American Home Products Corporation, Wyeth-Ayerst Laboratories, and Whitehall Robbins Healthcare), and IMPAX LABORATORIES, INC., APOTEX, INC. and NOVEX PHARMA, COPLEY PHARMACEUTICAL, INC., and GENPHARM, INC., Defendants-Appellees.
Subsequent History: Rehearing denied by, Rehearing, en banc, denied by Schering Corp. v. Geneva Pharms., Inc., 348 F.3d 992, 2003 U.S. App. LEXIS 22046 (Fed. Cir., Oct. 28, 2003)
Prior History: [**1] Appealed from: United States District Court for the District of New Jersey. Chief Judge John W. Bissell.
Schering Corp. v. Geneva Pharms., Inc., 275 F. Supp. 2d 534, 2002 U.S. Dist. LEXIS 14587 (D.N.J., 2002)
patent, prior art, anticipation, loratadine, compound, metabolite, subject matter, discloses, district court, disclosure, invention, ingestion, patient, pharmaceutical, skill, summary judgment, critical date, administering, metabolizes, covering, invalid, antihistamine, composition, enabling, infringe, genuine, missing, ribs, ordinary person, plastic bottle
Patent Law, Anticipation & Novelty, Elements, General Overview, Invention Date & Priority, Statutory Bars, Civil Procedure, Summary Judgment, Entitlement as Matter of Law, Appeals, Summary Judgment Review, Accidental Anticipation & Inherency, Specifications, Enablement Requirement, Defenses, Inequitable Conduct, Claims & Specifications, Invention Theory, Governments, Courts, Judicial Precedent, Preliminary Considerations, Venue, Utility Patents, Process Patents, Computer Software & Mental Steps, Infringement Actions, Infringing Acts, Standards & Tests, Reduction to Practice, Description Requirement, Product Patents, US Patent & Trademark Office Proceedings, Reissue Proceedings, Judgments, Evidentiary Considerations, Materiality of Facts